Isto Biologics

Isto Biologics is a biologics-focused company based in Hopkinton, MA, specializing in orthobiologic solutions for the spine, orthopedics, and sports medicine markets. The company develops regenerative technologies and innovative products aimed at supporting tissue repair and bone regeneration. Isto emphasizes autologous therapies and bone grafting solutions, continuously innovating to meet the needs of surgeons and partners. The product portfolio includes the Magellan® Autologous Concentration System for creating autologous therapies, such as Platelet Rich Plasma (PRP) and Concentrated Bone Marrow Aspirate. Isto also offers allograft products under the Influx™ brand, which serve as scaffolds for bone repair. Additionally, the InQu® biosynthetic bone graft substitute promotes faster bone fusion and provides a synthetic alternative to traditional grafts. Isto Biologics is committed to improving patient recovery through high-quality biologic solutions and partnerships with healthcare professionals, including surgeons, distributors, and researchers. The company focuses on advancing regenerative medicine and enhancing patient outcomes through its innovative product offerings.

• Employees170
• Founded1997
• Annual Revenue$50000000
• Total Funding$12535082